Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
22.39
+0.17 (0.77%)
At close: Sep 26, 2025, 4:00 PM EDT
22.37
-0.02 (-0.09%)
After-hours: Sep 26, 2025, 4:43 PM EDT

Apellis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 19 analysts that cover Apellis Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $33.47, which forecasts a 49.49% increase in the stock price over the next year. The lowest target is $18 and the highest is $57.

Price Target: $33.47 (+49.49%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$18$33.47$29$57
Change-19.61%+49.49%+29.52%+154.58%

Analyst Ratings

The average analyst rating for Apellis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy544433
Buy566677
Hold8999109
Sell000000
Strong Sell000001
Total181919192020

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Strong Sell
Downgrades
$26$18
Strong SellDowngrades$26$18-19.61%Sep 26, 2025
Mizuho
Mizuho
Hold
Maintains
$21$22
HoldMaintains$21$22-1.74%Aug 4, 2025
JP Morgan
JP Morgan
Buy
Maintains
$35$37
BuyMaintains$35$37+65.25%Aug 4, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$46$52
Strong BuyMaintains$46$52+132.25%Aug 1, 2025
RBC Capital
RBC Capital
Hold
Maintains
$17$19
HoldMaintains$17$19-15.14%Aug 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
954.11M
from 781.37M
Increased by 22.11%
Revenue Next Year
925.00M
from 954.11M
Decreased by -3.05%
EPS This Year
-0.53
from -1.60
EPS Next Year
-0.93
from -0.53
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
250.65M66.56M75.42M396.59M781.37M954.11M925.00M
Revenue Growth
--73.44%13.31%425.83%97.02%22.11%-3.05%
EPS
-4.59-8.84-6.15-4.45-1.60-0.53-0.93
EPS Growth
-------
Forward PE
-------
No. Analysts
-----2222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High1.1B1.1B
Avg954.1M925.0M
Low691.3M742.6M

Revenue Growth

Revenue Growth20252026202720282029
High
40.0%
12.8%
Avg
22.1%
-3.1%
Low
-11.5%
-22.2%

EPS Forecast

EPS20252026202720282029
High0.652.04
Avg-0.53-0.93
Low-2.24-2.20

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.